Three Awards for Health, Innovation, and Emergence
Each year, the Fondation Armand-Frappier recognizes exceptional accomplishments by companies in the health, biotechnology, and agri-food sectors by awarding three Fondation Armand-Frappier Prizes. The recipients of the Prizes are announced during the Fête Champêtre.
Louis-Philippe Vézina, Vice-President of Research & Development and Director, Medicago, Prix Santé 2011
Martin LeBlanc, CEO, Caprion protéomique, Prix Innovation 2011
The prizes are determined by the Foundation on the recommendation of the Science Committee.
Selection Criteria:
To be considered, the organizations must have conceived, developed, and commercialized a scientific or technological innovation, or be about to do so, or they must have made a remarkable contribution to research and development. They must also be established in Québec.
Health Prize
The Health Prize is a mark of recognition that the Foundation awards, on the recommendation of a jury, to organizations in honour of their success and the role they play in our mileu. It is reserved for organizations working in human, animal, or environmental health or the agri-food sector.
Health Prize Laureates
2011: Medicago
2010: Atrium Innovations
2009: Theratechnologies
2008: Pfizer Canada Inc.
2007: GlaxoSmithKline
2006 : Héma-Québec
2005 : DiagnoCure
2004 : Warnex inc.
2003 : Cryocath Technologies inc.
2002 : Montréal Genomics Centre and the Genome Québec Innovation Centre
2001 : Merck Frosst Therapeutic Research Centre
2000 : Roche Diagnostics
1999 : Axcan Pharma
1998 : Astra Montréal Research Centre
1997 : Hoechst Marion Roussel Canada
1996 : BioChem Pharma inc.
1995 : Rougier inc.
1994 : Bio-Méga Boehringer Ingelheim Recherche inc
Innovation Prize
The Innovation Prize, like the Health Prize, is a mark of recognition that the Foundation awards, on the recommendation of a jury, to organizations in honour of their success and the role they play in our mileu. It is reserved for organizations working in any industrial or commercial sector that distinguishes itself by the same criteria as the Health Prize, that is, for their efforts in the human, animal, or environmental field or the agri-food sector.
Innovation Prize Laureates
2011: Caprion Proteomique
2010 : Québec Consortium for Drug Discovery (CQDM)
2009 : Bio-K + International
2008 : Génome Québec
2007 : Genizon Biosciences inc.
2006 : Jewish Rehabilitation Hospital
2005 : Victhom Human Bionics.
2004 : ART Advanced Research Technologies Inc.
2003 : ProMetic Life Sciences
2002 : CQIB, The Life Sciences Incubator
2001 : INO Institut national d'optique
2000 : BioEnvelop Technologies Inc.
1999 : Nexia Biotechnologies
1998 : Novartis Pharma Canada Inc.
1996 : BioCapital Inc.
1995 : Cosmodôme
1994 : Softimage Inc.
Emergence Prize
The Emergence Prize is the outcome of a competition with a jury, following a public call for candidates. It is awarded to a young business established in Québec, with at least ten years of operation, working in human or environmental health, or the agri-food sector. This prize was awarded by the Fondation Armand-Frappier from 1994 to 2008.
Émergence Prize Laureates
2008 : Photon etc.
2007 : Variation Biotechnologies
2006 : Chronogen
2005 : Innodia inc.
2004 : Ecopia BioSciences Inc.
2003 : Phytobiotech Inc.
2002 : Caprion Pharmaceuticals
2001 : Neurochem inc.
2000 : Biovet Inc.
1999 : Quantum Biotechnologies
1998 : Theratechnologies Inc.
1997 : Algène Biotechnologies
1996 : Les Laboratoires Aeterna inc.
1995 : Biogénie Inc.
1994 : Haemacure Corporation
Science Committee
The Science Committee is composed of a Chair and expert members, who are appointed annually. Its role is to deliberate and submit recommendations for the Fondation Armand-Frappier Prizes for the year.
2011 :
Chair
- Jacques Gagné, Chair
CQIB, The Life Sciences Incubator
Members
- Damien Cloutier
Vice-President Business Strategy and Financing, Laval Technopole
- Marielle Gascon-Barré
Professor Emeritus, Faculty of Medicine, Université de Montréal
- Georges Lagacé
Industrial Technology Advisor, National Research Council of Canada
- Jean-Maurice Plourde, Président-directeur général
President and Chief Executive Officer CQVB Bio-Industries